Global Newborn Screening Market- Industry Trends & Forecast
global newborn screening market was worth USD 812.1 million in 2020. The data
gathered in the study suggest that the market is further projected to reach USD
1,479.4 million by 2027, at a CAGR of 9.3% during the forecast period
rising prevalence of newborn disorders, such as congenital diseases, and
neonatal diseases, along with increasing
healthcare budgets across the globe, are driving the market growth.
The global newborn screening market is also expected to grow due to technical
advancements in the field of medical science and carious diagnostic screening
procedures for the early detection of disorders. Furthermore, the government
and non-governmental organizations are taking up initiatives to improve
mother-child care, which is doubling the number of newborn screening programs
around the world. Additionally, favorable reimbursement policies in
several countries are also expected to fuel the growth of the global newborn screening
market in the coming years.
Source: Blue Weave Consulting
Newborn Screening Market Overview
Newborn screening is a process of detecting disorders/
diseases in newborn babies by using specialized devices, consumables,
instruments, etc. These screening procedures help to diagnose diseases in newborns.
The increasing cases of newborn diseases have been propelling the newborn
screening market growth. Government support coupled with non-governmental
organizations’ initiatives for mother & child care has pushed
the newborn screening market growth to the optimum level. The global
newborn screening market is being driven due to high concerns for the early
detection of diseases/disorders in newborns.
Newborn Screening Market Trend
The global newborn screening
market is experiencing rapid growth as frequent cases of infant-related
disorders are being recorded. With the rising newborn diseases, many key players have raised awareness
and support for using advanced screening instruments for early diagnosis.
Hearing, metabolic, and hormonal disorders and critical congenital heart
diseases are a few major disorders prevalent in newborns. The early diagnosis
of such diseases can help the doctors to treat them effectively.
WHO (World Health Organization) in its report published in 2020 claimed that children dying within the first 28 days of birth,
have suffered from diseases due to lack of quality care at the time of birth or
skilled care and treatment immediately post-birth.
Birth Rates in Emerging Market
the high-natality rates in some countries like India, China, Brazil, etc. the
risk for newborn diseases has also increased, which in turn has created
lucrative opportunities for the global newborn screening market. According to the UN, India records
25 million births each year which is nearly one-fifth of the global annual
childbirths. The high birth rate and the accessible newborn screening
procedures in public hospitals indicate an increasing demand for products and
consumables. Moreover, countries like China have mandated
Phenylketonuria (PKU), and a hearing test by including them
under national screening programs.
Healthcare Facilities and Infrastructure
of the major concerns across the global newborn screening market is related to
poor healthcare infrastructure & scarcity of skilled professionals. The
coronavirus outbreak has depicted several shortcomings in healthcare systems
even in emerging economies. Moreover, many countries have recorded falling GDP
due to the global economic crisis, which has ultimately caused lower spending
on healthcare. Moreover, inaccuracy and low precision of the devices, coupled
with the scarcity of skilled professionals, are further restraining the market
growth. However, several market players are also developing new models to enhance
the precision and accuracy of the kits and instruments.
COVID-19-induced pandemic has affected practically every industry around the world.
Due to the high infection rates and severe impact on public health systems, several
countries had to enforce nationwide lockdowns, which significantly impacted
industrial supply chains, trade, and related services. The pandemic, on the
other hand, had a negligible influence on the global newborn screening market. Soon
after the outbreak of the pandemic, strict restrictions were put in place to
monitor infant health and safeguard neonates against COVID-19. Many diagnostic
laboratories and government agencies have also sought to raise health awareness
Newborn Screening Market by Product Type
on the product type, the global newborn screening market is divided into two
categories namely consumables, & instruments. Consumables are further classified into assay
kits & reagents, and other consumables. On the other hand, the instrument
section is divided into three sections, namely pulse oximeter, newborn hearing
screening, which comprises different devices and accessories, and other
instruments. The consumables segment accounts for the largest market share due to the constant demand for consumables
in newborn screening. Also, increasing newborn disease prevalence and rising health
concerns for infants across the globe are the major driving factors that
support the growth of consumables.
Source: Blue Weave Consulting
Newborn Screening Market by Test Type
on the test type, the global newborn screening market is divided into four main
categories- dried blood spot, hearing screening,
critical congenital heart defect (CCHD), and other test types.
Different test types are used for different purposes. Due to the wide acceptance of dry
blood spot tests for screening disorders, and its ability to diagnose
metabolic, hormonal, and genetic disorders in the newborn, the dried blood spot
segment dominates the market. A dried blood spot is also called a heel-stick as
the blood is collected from the heel of a newborn.
Newborn Screening Market by Technique
on techniques, the global newborn screening market is divided into the following
segments- tandem mass spectrometry, pulse oximetry,
enzyme-based assays, DNA assays, and other technologies. Among these, the enzyme-based assays, also known as immune assays, dominate the global
newborn screening market. This is due to the wide acceptance of these assays for
screening disorders in newborns. This screening procedure implies enzyme-linked
immunosorbent assays (ELISA), which help to detect antigens or antibodies by
producing a color change. This test is used to detect any disorder that might
have been transferred from mother to child during pregnancy.
Newborn Screening Market by End-User
on end-users, the global newborn screening market is fragmented into
diagnostics centers, hospitals, and other end users. Hospitals dominate the
newborn screening industry since hospitals are where most babies are born. Moreover,
hospitals can also detect and diagnose any complications that might have
transferred from mother to child immediately after the child's birth. Diagnostic
centres, on the other hand, are only equipped to provide screening facilities
related to different disorders. They provide pathological and radiological testing,
along with a doctor to analyze, and verify the reports.
Newborn Screening Market Regional Insights
on regions, the global newborn screening market is segmented into North
America, Europe, Asia-Pacific, South America, Middle East, and Africa. Among these regions, North America owns the
largest market share due to the growing
prevalence of congenital disorders and mandatory testing in all the states of
the nation. Additionally, the rising demand for advanced screening systems
due to the increasing incidence of newborn disorders, favorable reimbursement policies, and a
presence of key players in the
region have fueled the global newborn screening market in North America. Additionally, the Asia Pacific is
anticipated to witness the fastest growth. This can be attributed to high
natality rates, increasing screening rates, and rising awareness regarding the early
diagnosis of severe disorders in infants.
Source: Blue Weave Consulting
global newborn screening market is a concentrated market, with several key
players and a diverse range of products. Manufacturers are
continually focusing on innovation to produce neonatal genetic screening
technologies and kits for the early detection of diseases in newborns. This is
expected to further drive the global newborn screening market. Some of the key
players in the market are Natus
Medical Incorporated, AB Sciex, Masimo Corporation, GE Healthcare, Medtronic
Inc., Bio-Rad Laboratories Inc., PerkinElmer Inc., ZenTech SA, Demant A/S,
Waters Corporation, Trivitron Healthcare, Thermo Fisher Scientific, Hill-Rom
Holdings, Inc., and other prominent players.
- In January
Genetics announced the launch of an expanded neonatal genetic screening
test for newborns, infants, and children by the name Orean.
- In September
global corporation, PerkinElmer, attained approval
for EONIS screening assay. The approval will allow the company to integrate
its newborn test for SCID (severe combined immunodeficiency), SMA (spinal
muscular atrophy), and XLA (X-linked agammaglobulinemia) in newborns.
Scope of the Report:
data – 2017-2020
Year – 2020
– 2021 – 2027
in USD Million
The U.S., Canada, Germany, Italy, U.K., France, Spain, Rest of Europe, Japan, China, India, South Korea, Australia, Rest of Asia-Pacific,
Brazil, Mexico, Argentina, etc.
By Product, By Type, By Test, By
Technique, By End-User, and By Region
AB Sciex, Bio-Rad Laboratories Inc., GE Healthcare, Masimo Corporation, Medtronic Inc., Natus Medical Incorporated, PerkinElmer Inc., Trivitron Healthcare, ZenTech SA, Demant A/S, Waters Corporation, Thermo Fisher Scientific, Hill-Rom Holdings, Inc., and
other prominent players.
By Product Type
Assay Kits &
By Test Type
Dried Blood Spot
Heart Defect (CCHD)
Other Test Types
Enzyme Based Assays
Other End Users
The Middle East and
is the current size of the global newborn screening market?
Answer: The global newborn
screening market reached USD 812.1 million in 2020.
What are the major
factors driving the growth of the global newborn screening market?
prevalence of disorders in newborn babies, increasing healthcare budgets across the globe, high birth
rates in emerging markets, initiatives to facilitate
mother & child care followed by several reimbursement policies are a few
factors driving the market growth.
Who are the key
players in the global newborn screening market?
The key players operating in the global newborn screening market are AB Sciex, Bio-Rad Laboratories Inc., GE Healthcare,
Masimo Corporation, Medtronic Inc., Natus Medical Incorporated, PerkinElmer
Inc., Trivitron Healthcare, ZenTech SA, Demant A/S, Waters Corporation, Thermo
Fisher Scientific, Hill-Rom Holdings, Inc., and
other prominent players
accounted for the largest share in the global newborn screening market by test
Answer: The dry blood
spot test segment accounted for a larger revenue share due to the high
acceptance and its ability to detect many newborn disorders
Which region is
growing at a higher rate in the global newborn screening market?
Pacific is anticipated to show the fastest growth. This can be attributed to
high natality rates, increasing screening rates, and rising awareness regarding
the early diagnosis of severe disorders.